| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/24/2005 | DE10339862A1 New crystalline forms of ethyl 3-(N-(2-(4-(hexyloxycarbonylamidino)ph enylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-N-(2-pyridyl)a mino)propionate methanesulfonate used for post-operative prophylaxis of deep vein thrombosis |
| 03/24/2005 | DE10339549A1 New glucopyranosyloxy-pyrazole derivatives are sodium dependent glucose cotransporter inhibitors used for treating and preventing metabolic disorders, particularly diabetes |
| 03/24/2005 | DE10339157A1 Use of histamine antagonists against itching in outer auditory canal, especially by topical application |
| 03/24/2005 | DE10338544A1 Film for buccal administration comprises galanthamine and polymer layer, useful for treating diseases associated with defective acetylcholine-mediated signal transduction and/or dysregulation of neuronal nicotinic receptors |
| 03/24/2005 | DE10338174A1 Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit Transdermal drug formulations with drug combinations for the treatment of Parkinson's disease |
| 03/24/2005 | DE10338090A1 Use of diflunisal (5-(2,4-difluorophenyl)-salicylic acid) for the preparation of a medicament for the treatment of cancers |
| 03/24/2005 | DE10337905A1 Using apoptosis-regulating agent for treating disease, e.g. neurodegeneration or autoimmune diseases, acts by modifying interaction of mitochondrial potassium channels with apoptosis inducers |
| 03/24/2005 | DE10337904A1 Using apoptosis-inducing or stimulating agent for treating disease, particularly infections or tumors, acts by interaction with mitochondrial potassium channels |
| 03/24/2005 | DE10337697A1 Tablette enthaltend Tablet containing 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze or salts thereof |
| 03/24/2005 | DE10337638A1 Verfahren zur Behandlung der Prostatitis A method for the treatment of prostatitis |
| 03/24/2005 | DE10336400A1 Gegen Missbrauch gesicherte Darreichungsform Abuse-proofed dosage form |
| 03/24/2005 | DE102004042021A1 Use of chitin, chitosan or their derivatives for prophylactic and therapeutic purposes in agricultural livestock production |
| 03/24/2005 | DE102004041612A1 Extraction of carotene, Vitamin E and other minor components from natural oils and fats, for use in pharmaceuticals and food products, involves extraction of a concentrate with supercritical fluid, preferably carbon dioxide |
| 03/24/2005 | DE102004028302A1 Stimulierung der Synthese und der Aktivität einer Isoform der Lysyloxidase-ähnlichen LOXL zum Stimulieren der Bildung von elastischen Fasern Stimulation of the synthesis and the activity of one isoform of the lysyl oxidase-like LOXL for stimulating the formation of elastic fibers |
| 03/24/2005 | DE10006836B4 Verwendung von Omega-3-Fettsäuren und/oder Verbindungen von Omega-3-Fettsäuren The use of omega-3 fatty acids and / or compounds of omega-3-fatty acids |
| 03/24/2005 | CA2810312A1 Novel crystalline polymorphs of clopidogrel |
| 03/24/2005 | CA2809750A1 Novel crystalline polymorphs of clopidogrel |
| 03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
| 03/24/2005 | CA2551022A1 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 03/24/2005 | CA2541100A1 Quinazoline derivatives |
| 03/24/2005 | CA2539454A1 Preventive for cerebral stroke recurrence |
| 03/24/2005 | CA2539286A1 Use of n-acetyl-d-aminoglycosamine in preparation of drugs for modulating microorganisms on mucous membrane |
| 03/24/2005 | CA2539160A1 Antibacterial agents |
| 03/24/2005 | CA2539158A1 Crystalline forms of ['r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid |
| 03/24/2005 | CA2539049A1 Quinazoline derivatives |
| 03/24/2005 | CA2539041A1 Dry powder composition comprising a benzodiazepine for pulmonary inhalation |
| 03/24/2005 | CA2539033A1 Treatment of disease or injury of the nervous system with fty720 |
| 03/24/2005 | CA2539024A1 Quinazoline derivatives as antitumor agents |
| 03/24/2005 | CA2539022A1 Quinazoline derivatives as tyrosine kinase inhibitors |
| 03/24/2005 | CA2539016A1 Organic compounds |
| 03/24/2005 | CA2539000A1 Combination of a histone deacetylase inhibitor with a death receptor ligand |
| 03/24/2005 | CA2538997A1 Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation |
| 03/24/2005 | CA2538910A1 Use of known active ingredients as radical scavengers |
| 03/24/2005 | CA2538909A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 03/24/2005 | CA2538883A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 03/24/2005 | CA2538843A1 Animal model for protease activity and liver damage |
| 03/24/2005 | CA2538829A1 Ceratamines a and b, and analogues, syntheses and pharmaceutical compositions thereof |
| 03/24/2005 | CA2538759A1 Substituted heterocyclic compounds as sirtuin inhitibitors |
| 03/24/2005 | CA2538755A1 Granular jelly drink capable of masking bitterness |
| 03/24/2005 | CA2538617A1 Skincare compositions comprising salicylic acid |
| 03/24/2005 | CA2538552A1 Pyrrol derivatives with antibacterial activity |
| 03/24/2005 | CA2538495A1 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538442A1 Eukaryotic genes for modulating cell cycle progression |
| 03/24/2005 | CA2538434A1 Novel indolopyrrolocarbazole derivative with antitumor activity |
| 03/24/2005 | CA2538425A1 Crystals of a heterocyclic compound |
| 03/24/2005 | CA2538420A1 Quinolone antibacterial agents |
| 03/24/2005 | CA2538416A1 A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug. |
| 03/24/2005 | CA2538415A1 Use of antagonists of hepatic sympathetic nerve activity |
| 03/24/2005 | CA2538413A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 03/24/2005 | CA2538412A1 Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders |
| 03/24/2005 | CA2538410A1 2-pyridone derivatives as netrophil elastase inhibitors and their use |
| 03/24/2005 | CA2538399A1 Pharmaceutical compostions |
| 03/24/2005 | CA2538339A1 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase |
| 03/24/2005 | CA2538333A1 Multi-system therapy for diabetes, the metabolic syndrome and obesity comprising a hypoglycemic agent |
| 03/24/2005 | CA2538315A1 Matrix metalloproteinase inhibitors |
| 03/24/2005 | CA2538245A1 Oligonucleotides targeting prion diseases |
| 03/24/2005 | CA2538237A1 Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation |
| 03/24/2005 | CA2538231A1 A method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration |
| 03/24/2005 | CA2538202A1 Use of ciclesonide for the treatment of inflammatory bowel diseases |
| 03/24/2005 | CA2538188A1 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 03/24/2005 | CA2538073A1 Formulations and methods for treating breast cancer with morinda citrifolia and methylsulfonymethane |
| 03/24/2005 | CA2538026A1 Crf antagonists and heterobicyclic compounds |
| 03/24/2005 | CA2538009A1 Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias |
| 03/24/2005 | CA2537860A1 Gyrase inhibitors |
| 03/24/2005 | CA2537841A1 Modulators of atp-binding cassette transporters |
| 03/24/2005 | CA2537837A1 Treating and/or preventing urinary incontinence using prodrugs of gaba analogs |
| 03/24/2005 | CA2537820A1 Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins |
| 03/24/2005 | CA2537794A1 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and carbamoyloxy compounds as therapeutic agents |
| 03/24/2005 | CA2537695A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same |
| 03/24/2005 | CA2537663A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/24/2005 | CA2537660A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/24/2005 | CA2537430A1 Ophthalmic compositions for treating ocular hypertension |
| 03/24/2005 | CA2537343A1 Treatment of gastroparesis and nonulcer dyspepsia with gabab agonists |
| 03/24/2005 | CA2536746A1 Hydrophobic drug compositions containing reconstitution enhancer |
| 03/24/2005 | CA2536633A1 Fused ring heterocycles as potassium channel modulators |
| 03/24/2005 | CA2536107A1 Substituted piperazines of azepines, oxazepines, and thiazepines |
| 03/24/2005 | CA2536052A1 Novel crystalline compounds |
| 03/24/2005 | CA2535373A1 Methods for the controlled delivery of pharmacologically active compounds |
| 03/24/2005 | CA2535221A1 Chimeric gabab receptor |
| 03/24/2005 | CA2534957A1 Antibiotic cycloalkyltetrahydroquinoline derivatives |
| 03/24/2005 | CA2533926A1 Methods and compositions for producing antigenic responses |
| 03/24/2005 | CA2530510A1 Improved delivery by labile hydrophobic modification of drugs |
| 03/24/2005 | CA2504885A1 Agent containing ergolin for transdermal application |
| 03/24/2005 | CA2476224A1 Compound and use in treatment |
| 03/23/2005 | EP1516882A1 Composition containing a marine-derived inorganic substance and chitin/chitosan, and method of producing the composition |
| 03/23/2005 | EP1516881A2 Composition and method for modulating dendritic Cell-T cell interaction |
| 03/23/2005 | EP1516878A1 Refreshment capable of stimulating movement of digestive tract |
| 03/23/2005 | EP1516877A1 Amine derivatives as protease inhibitors |
| 03/23/2005 | EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto |
| 03/23/2005 | EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/23/2005 | EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/23/2005 | EP1516872A1 Novel azasugar derivative and drug containing the same as the active ingredient |
| 03/23/2005 | EP1516871A1 Benzoindoline derivatives with adrenergic activity |
| 03/23/2005 | EP1516866A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
| 03/23/2005 | EP1516639A1 Device in the treatment of pulmonary vasoconstriction and asthma |
| 03/23/2005 | EP1516631A1 Body ointment having decongestant effect and for the progressive relief of muscular pain, sprains, wrenchs, dislocations, aches and for relief of articular and rheumatic pain |
| 03/23/2005 | EP1516624A1 Method of producing calcium gluconolactate, compositions, processes and uses of same |
| 03/23/2005 | EP1516623A1 Drug for prevention and/or treatment of constipation and symptom caused by constipation |
| 03/23/2005 | EP1516622A1 Stable diltiazem hydrochloride pharmaceutical composition for cutaneous application and process for the preparation thereof |
| 03/23/2005 | EP1516621A2 Use of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of cell proliferation diseases |